This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

"Fountain Of Youth" Pill SeroVital™-hgh Huge Draw At D.C. Women's Health Conference

The problem is that while our bodies do manufacture hGH, our levels begin to decline rapidly as we age, and until recently the best way to increase our hGH levels was through expensive prescription injections (costs can run as high as $1500 per month). In addition to their high cost, these synthetic hGH injections are also extremely controversial, because some experts fear that introducing synthetic into the body may upset the natural production of hGH.

"That's what makes SeroVital so revolutionary," says Dr. Amy Heaton, PhD, Director of Scientific Affairs for SanMedica International™, SeroVital's distributor. "Rather than introducing synthetic hGH into the body like the injections do, SeroVital raises the body's own, natural levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. And the women's health experts I'm meeting with here at the conference are excited to learn that SeroVital can not only provide the women in their care with a more affordable way to raise their hGH levels, but can offer a clinically proven way to achieve this naturally, without injections."

SeroVital's research began making headlines when it was first presented at The Obesity Society's most recent Annual Scientific Meeting in San Antonio, Texas, where a group of some of the world's most renowned researchers revealed that this tiny little pill was actually capable of increasing mean, serum (blood) growth hormone levels... by an astounding 682%.

And although SanMedica is enjoying all the popular media attention it's received, the company was excited to get back to its research roots by taking SeroVital to the Women's Health Conference. "We've been thrilled about the opportunity to share our research with the highly respected group of women's healthcare providers who are attending the conference," says Dr. Heaton, who has been available at the conference to answer any questions. "The research behind SeroVital is not only revolutionary because it proves there's an oral compound capable of increasing growth hormone levels naturally — without synthetic injections — but also because it was the first clinical trial of its kind to test a compound's growth hormone boosting effects not just on young males, but on both men and women across an appropriately wide age range. We think it's important to let women's health experts know just how well women responded to the SeroVital complex."

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs